ENASIDENIB for Leukaemia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 55 adverse event reports in the FDA FAERS database where ENASIDENIB was used for Leukaemia.
Most Reported Side Effects for ENASIDENIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 650 | 17.6% | 650 | 14 |
| Off label use | 213 | 5.8% | 26 | 35 |
| Fatigue | 202 | 5.5% | 5 | 41 |
| Nausea | 197 | 5.3% | 5 | 40 |
| Acute myeloid leukaemia | 163 | 4.4% | 95 | 43 |
| Hospitalisation | 149 | 4.0% | 2 | 145 |
| Diarrhoea | 144 | 3.9% | 1 | 35 |
| Decreased appetite | 122 | 3.3% | 3 | 35 |
| Platelet count decreased | 113 | 3.1% | 3 | 45 |
| Drug ineffective | 108 | 2.9% | 7 | 16 |
| Differentiation syndrome | 102 | 2.8% | 19 | 66 |
| Pneumonia | 91 | 2.5% | 14 | 69 |
| Pyrexia | 90 | 2.4% | 9 | 71 |
| Asthenia | 89 | 2.4% | 2 | 39 |
| Full blood count decreased | 75 | 2.0% | 2 | 37 |
Other Indications for ENASIDENIB
Acute myeloid leukaemia (2,220)
Product used for unknown indication (657)
Myelodysplastic syndrome (304)
Off label use (181)
Myeloid leukaemia (58)
Acute myeloid leukaemia recurrent (51)
Cholangiocarcinoma (48)
Glioma (34)
Acute myelomonocytic leukaemia (32)
Acute myeloid leukaemia (in remission) (31)
Other Drugs Used for Leukaemia
DASATINIB (654)
VENETOCLAX (307)
CYTARABINE (288)
METHOTREXATE (282)
IMATINIB (281)
RUXOLITINIB (230)
NILOTINIB (203)
BOSUTINIB (191)
VINCRISTINE (172)
CYCLOPHOSPHAMIDE (153)